Hundreds contact BBC about mystery skin condition ‘hell’ – but doctors can’t agree it exists

Hundreds Contact BBC About Mysterious Skin Condition ‘Hell’ – Doctors Remain Divided

Two weeks prior, I authored a BBC News piece detailing the growing concern around a challenging skin issue shared widely on social media, termed topical steroid withdrawal (TSW). For some individuals, it mirrors extreme eczema cases, while others argue it is a distinct condition. Yet, medical experts still debate its classification, leading to confusion. The article sparked significant engagement, with millions reading it and 240 readers reaching out for more information. What does this reveal about the debate?

The Struggle of Bethany Norman

In the hospital, with her arms wrapped in bandages, Bethany Norman clutched her newborn son. He had eczema, but she refused to apply steroid creams, defying medical advice. “Look at what this medication has done to me? Why would I put it on my own son?” she recalls shouting. The 36-year-old claims the creams prescribed for her lifelong eczema battles left her with TSW. At that time, her skin was marred by open wounds, a bone-deep itch that never subsided, and relentless shedding. She described feeling trapped in her own body, fearing her baby might face the same fate.

“I’ve been told by countless medics that all I have is a severe eczema flare-up and steroids will fix it. They just made it worse,” she says.

Steroid creams have been a staple since the 1950s, aiding millions in managing eczema and maintaining daily routines. Ranging from mild over-the-counter hydrocortisone to stronger prescription variants, they are often considered first-line treatments. However, a growing number of patients now question their efficacy, claiming these creams do not always resolve their symptoms.

Medical Perspectives on TSW

In 2021, the MHRA, UK’s medicine regulator, acknowledged TSW as a reaction to prolonged steroid cream use—but not as a formally diagnosed condition. This lack of clarity fuels ongoing tensions between patients and healthcare providers. Dr. Pippa Bowes, an urgent care physician in Southampton specializing in acute dermatology, notes: “There can be a breakdown of communication. Patients sometimes feel unheard, and professionals struggle to grasp the situation.”

Jenna Crosbie, a trainee GP in north Wales, initially found it perplexing that someone like Bethany would avoid steroid creams. Her medical training emphasized their role as primary treatments for eczema. Yet, after observing a patient with TSW in A&E, she was struck by the severity of the symptoms. “It looked like the most intense full-body eczema I’d ever seen,” she says. “I couldn’t understand why they’d refuse steroids.”

Later, Crosbie noticed her own skin condition worsening despite using more steroids during night shifts. After researching and comparing her symptoms to eczema, she opted to discontinue the creams. Her GP supported this decision, allowing her to empathize with the A&E patient’s ordeal. “I wouldn’t wish it on my worst enemy,” she adds.

The Debate Over Steroid Creams

Could some doctors inadvertently contribute to TSW by prescribing steroids too readily? Dr. Dean Eggit, a GP in Doncaster, suggests this possibility. He acknowledges that GPs might quickly assume a red rash indicates eczema and reach for steroids without investigating further. “Unfortunately, TSW can begin to resemble the original eczema rash,” he explains. “This means we risk continuing to prescribe the very creams that might be triggering the condition.”

The National Institute for Health and Clinical Excellence (NICE) outlines a step-up and step-down strategy for eczema, starting with emollients before introducing steroids. However, this approach relies on follow-ups to monitor progress. Dr. Adrian Hayter from the Royal College of GPs highlights: “If a patient is on a repeat prescription, we need to ensure they’re using them appropriately and that the treatment is working as intended.” Despite these guidelines, the debate over TSW persists, with no definitive consensus in sight.